- Joined
- Apr 21, 2011
- Messages
- 3,746
- Reaction score
- 9,566
The chart is limited to Holman Path only, not the specialty's residency at large. The conclusion we can draw is that they're shunning the Holman Pathway (though I suspect that does indeed apply to the broader specialty).The numbers here are very strange. A single first year MD/PhD for 3 years with 93 residual active MD/PhDs as of 2020? This in a residency that is 4-5 years long? Was half the class from 2017 MD/PhD? Just doesn't seem plausible. Are there residual MD/PhDs extending their training through fellowship and counting as active?
Unless the data is somehow wildly misrepresented, this reveals a radical shunning of the field by MD/PhDs. (It should be noted that this table refers to the real deal: Dual degree MD/PhD from US med school, not jokers like me who had a PhD and then went to med school.)
If it does represent a radical shunning, there is likely one reason for this, and it is not SDN. MD/PhD folks are typically very close to their very small cohort and classes ahead of them. I suspect downstream MD/PhDs must have been discouraging their upstream friends based on personal experience.
Edit: I noticed that no specialty without commonly integrated PGY-1 had significant numbers of first year MD/PhD's listed. I suspect this explains the tiny number of listed first year residents.
The trend remains significant but not radical. Nineteen fewer MD/PhDs in 2020 vs 2018, likely with significant frontloading of the duel degree cohort among remaining more senior classes.
Basically flipped overnight from all MD/PhDs to all MDs.
Best guess is the participants found it to be unproductive and had limited post graduation opportunities to further research (i.e. they ended up in academic satellite seeing bone mets), and thus discouraged their fellow MD/PhDs from pursuing.